Remission of resistant MPGN type I with mycophenolate mofetil and steroids

Pediatric Nephrology

Volumn 24, Issue 3, 2009, Pages 597-600

  De, Sudarsana ^a   Al Nabhani, Dana ^a   Thorner, Paul ^a,b,c   Cattran, Daniel ^c,d   Piscione, Tino D ^c   Licht, Christoph ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Membranoproliferative glomerulonephritis type I; Mycophenolate mofetil; Prednisone; Proteinuria

Indexed keywords

ALBUMIN; AMLODIPINE; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG METABOLITE; FUROSEMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMEPRAZOLE; PREDNISOLONE; STEROID;

ALBUMIN BLOOD LEVEL; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; EDEMA; HEMATURIA; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; LABORATORY TEST; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; REMISSION; SCHOOL CHILD; UPPER RESPIRATORY TRACT INFECTION;

CHILD; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MALE; MYCOPHENOLIC ACID; PREDNISONE;

EID: 59849099007     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-1023-7     Document Type: Article

References (11)

1. Tarshish P, Bernstein J, Tobin JN, Edelmann CM Jr (1992) Treatment of mesangiocapillary glomerulonephritis with alternate day prednisone - a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6:123-130
2. Levin A (1999) Management of membranoproliferative glomerulonephritis: Evidence-based recommendations. Kidney Int 55(Suppl 70):S41-S46
3. Jones G, Juszczak M, Kingdon E, Harber M, Sweny P, Burns A (2004) Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids. Nephrol Dial Transplant 19:3160-3164
4. D'Amico G, Ferrario F (1992) Mesangiocapillary glomerulonephritis. J Am Soc Nephrol 2:S159-S166
5. Cattran DC, Cardella CJ, Roscoe JM, Charron RC, Rance PC, Ritchie SM, Corey PN (1985) Results of a controlled drug trial in membranoproliferative glomerulonephritis. Kidney Int 27:436-441
6. Orlowski T, Rancewicz Z, Lao M, Juskowa J, Klepacka J, Gradowska L, Morzycka-Michalik M, Glyda J (1988) Long-term immunosuppressive therapy of idiopathic membranoproliferative glomerulonephritis. Klin Wochenschr 66:1019-1023
7. Faedda R, Satta A, Tanda F, Pirisi M, Bartoli E (1994) Immunosuppressive treatment of membranoproliferative glomerulonephritis. Nephron 67:59-65
8. Haddad M, Lau K, Butani L (2007) Remission of membranoproliferative glomerulonephritis type I with the use of tacrolimus. Pediatr Nephrol 22:1787-1791
9. Yi ZW, Dang XQ, He QN, Wu XC, Cao Y, Huang DL, He XJ, Mo SH (2007) Assessment of mycophenolate mofetil for treatment of frequently relapsing nephrotic syndrome in children. Zhong Nan Da Xue Xue Bao Yi Xue Ban 32:938-940
10. Choi MJ, Eustace JA, Gimenez LF, Atta MG, Scheel PJ, Sothinathan R, Briggs WA (2002) Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 61:1098-1114
11. Chan TM, Tse KC, Tang CS, Mok MY, Li FK (2000) Efficiency of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Eng J Med 343:1156-1162